Evaluation of Hypoglycemia in Neonates of Women at Risk for Late Preterm Delivery: An Antenatal Late Preterm Steroids Trial Cohort Study.
Cynthia Gyamfi-BannermanKathleen A JablonskiSean C BlackwellAlan T N TitaUma M ReddyLucky JainGeorge R SaadeDwight J RouseErin A S ClarkJohn M ThorpEdward K ChienAlan M PeacemanRonald S GibbsGeeta K SwamyMary E NortonBrian M CaseySteve N CaritisJorge E TolosaYoram SorokinJ Peter VanDorstennull nullPublished in: American journal of perinatology (2021)
· Hypoglycemia was transient and approximately two-thirds received no treatment.. · Neonates in the ALPS trial who received betamethasone had a shorter time to resolution than those with hypoglycemia in the placebo group.. · Prolonged hypoglycemia occurred in approximately 2 out of 100 late preterm newborns, irrespective of antenatal steroid exposure..
Keyphrases
- low birth weight
- preterm birth
- type diabetes
- preterm infants
- gestational age
- pregnant women
- phase iii
- glycemic control
- study protocol
- clinical trial
- phase ii
- polycystic ovary syndrome
- double blind
- placebo controlled
- open label
- pregnancy outcomes
- single molecule
- insulin resistance
- blood brain barrier
- subarachnoid hemorrhage
- adipose tissue
- smoking cessation